Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)
In: ISSN: 0270-9139, 2023
academicJournal
Zugriff:
International audience ; Approximately 30% of the worldwide population has at least one risk factor for liver disease. Identifying advanced liver disease before the occurrence of complications remains a difficult challenge in clinical practice, where diagnosis comes too late for many patients, at the time of liver decompensation or palliative hepatocellular carcinoma, with poor short-term prognosis. Noninvasive, blood- or elastography-based tests of liver fibrosis (NITs) have been developed for the early diagnosis of advanced liver fibrosis. Recent population-based studies evaluating the screening of liver fibrosis with these NITs have provided important information on at-risk groups that should be targeted. New measures based on the sequential use of NITs help to better organize the referral of at-risk patients to the liver specialist. However, energizing these measures will require increased awareness of both chronic liver diseases and the use of NITs among non-specialists.
Titel: |
Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)
|
---|---|
Autor/in / Beteiligte Person: | Nabi, Oumarou ; Lapidus, Nathanaël ; Boursier, Jérôme ; de Ledinghen, Victor ; Petit, Jean-Michel ; Kab, Sofiane ; Renuy, Adeline ; Zins, Marie ; Lacombe, Karine ; Serfaty, Lawrence ; Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques (HIFIH) ; Université d'Angers (UA) |
Link: | |
Zeitschrift: | ISSN: 0270-9139, 2023 |
Veröffentlichung: | HAL CCSD ; Wiley-Blackwell, 2023 |
Medientyp: | academicJournal |
DOI: | 10.1097/HEP.0000000000000329 |
Schlagwort: |
|
Sonstiges: |
|